NeuroBo Pharmaceuticals, Inc. SC 13D and SC 13D/A reports

Location
545 Concord Avenue, Suite 210, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/7/2024, 04:11 PM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SCHEDULE 13D/A, AMENDMENT #7 Sep 20, 2024
SC 13D/A Report SCHEDULE 13D/A, AMENDMENT #6 Jun 25, 2024
SC 13D/A Report SCHEDULE 13D/A, AMENDMENT #5 Dec 30, 2022
SC 13D/A Report SCHEDULE 13D (AMENDMENT NO. 4) Nov 10, 2022
SC 13D/A Report Sep 23, 2022
SC 13D/A Report SCHEDULE 13D (AMENDMENT NO. 3) Sep 16, 2022
SC 13D/A Report SCHEDULE 13D/A Aug 5, 2022
SC 13D/A Report Nov 10, 2021
SC 13D/A Report SCHEDULE 13D (AMENDMENT #2) Sep 1, 2021
SC 13D/A Report SCHEDULE 13D/A Aug 30, 2021
SC 13D/A Report SCHEDULE 13D/A, AMENDMENT #1 Aug 30, 2021
SC 13D/A Report SCHEDULE 13D/A Mar 15, 2021
SC 13D Report SCHEDULE 13D Mar 11, 2021
SC 13D/A Report SCHEDULE 13D AMENDMENT 1 Jan 16, 2020
SC 13D Report SCHEDULE 13D Jan 10, 2020
SC 13D Report SCHEDULE 13D Jan 10, 2020
SC 13D/A Report SC 13D/A Jan 10, 2020
SC 13D Report SC 13D Aug 2, 2019
SC 13D Report SC 13D Aug 2, 2019